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Magnetic resonance imaging (MRI) is the fastest growing
standard of care in diagnostic imaging. Because of its unique
properties such as noninvasive accurate assessment of left
ventricular (LV) volumes and regional LV wall motion abnor-
malities, quantification of flow and tissue characterisation,
MRI utilisation in the US is still growing at approximately
3 % per year [1]. Moreover, indications for MRI may expand
due to innovative techniques such as magnetic resonance
angiography (MRA) or the use of targeted contrast agents.
This increased usage of MRI is paralleled by an annual
growth of de novo pacemakers (>700,000) and implantable
cardio-defibrillators (>200,000) [2]. Since many recipients of
pacemakers and ICDs have substantial comorbidities, it is
estimated that up to 75 % will develop an indication for
MRI examination during further life [3, 4].
The hazards of MRI examination in patients with pace-
makers and ICDs are a consequence of the techniques used
[5]. First the static magnetic field may yield mechanical forces
on ferromagnetic components and may have unpredictable
magnetic sensor activation. Second, the modulated radiofre-
quency (RF) field may cause heating of cardiac tissue adjacent
to the lead tip, may induce life-threatening arrhythmias and
may interact with the device leading to over- or under-sensing.
Third, the gradient magnetic field may induce life-threatening
arrhythmias or may cause over- or under-sensing. Finally,
combined field effects can alter device function or lead to
electronic reset. Electrical reset may have major implications
since it can cause pacemaker inhibition or induce fatal tachy-
arrhythmias. Currently, MRI conditional CIEDs have become
available in which the risk of an electronic reset is significant-
ly reduced by adaptations in the device. Moreover, lead design
has been improved to avoid tip heating.
In this issue of the Netherlands Heart Journal Van der
Graaf and co-workers give an excellent overview of the cur-
rent status of MRI in patients with cardiac implantable elec-
tronic devices (CIED) [6]. They underline that although safety
in these patients who are scheduled for MRI examination has
traditionally been regarded a major issue, the recently pub-
lished European Society of Cardiology (ESC) guidelines ex-
press a different view [7]. These 2013 guidelines state that
MRI can be safely performed irrespective of the properties of
the CIED, the type of MRI examination or patient character-
istics such as presence or absence of underlying rhythm, as
long as safety restrictions are met. Differences in risk between
chest and non-chest MRI are not mentioned. Moreover, the
absolute number of patients on which these guidelines are
based is limited. A total of seven studies each report on small
numbers of chest MRIs. For example, in the study by Sommer
and co-workers on MRI in 51 patients only 5 had chest
scanning, and Naehle and colleagues reported on 18 CIED
patients but only 8 patients had examinations of the chest [8,
9]. In a larger study, Mollerus evaluated 127MRI scans in 103
patients of which 62 were chest MRIs [10]. No threshold
elevation was found, but both sensing amplitudes and pacing
impedances significantly changed. By far the largest study
was conducted by Nazarian and co-workers in 438 patients
with pacemakers and ICDs [11]. In this study, pacemaker-
dependent patients with an ICD were excluded. In 89 patients
chest MRI was performed. Three of the 438 patients had an
electrical reset (power-on-reset) leading to occasional pacing
inhibition in 2 patients. There were no symptomatic events in
these non-pacemaker dependant individuals. In the studies
mentioned CRT devices are strongly underrepresented.
Thus, current guidelines concerning MRI in patients with
CIED are based on a limited number of relatively small studies
in patients with a wide range of devices and leads, typically
excluding pacemaker-dependent patients as well as patients
with CRT devices. The evidence for safety of chest MRI is
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based on less than 200 patients and potentially associated
arrhythmias are still reported. Although the recent guidelines
have become more lenient and major complications have
rarely been reported, risk assessment in patients with CIED
is not straightforward. We would therefore advocate a prudent
approach in scheduling patients with CIED for MRI examina-
tion, especially those with older type or CRT devices and when
using newer (3T) MRI suites. MRI provides mesmerising
image quality, but mesmerisation of CIED should be avoided.
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